Maynard Um
-
-
-
-
-
-
-
Spero Therapeutics (SPRO) Tops Q4 EPS by 73c, Beats on Revenue
-
-
-
-
-
-
-
Spero Therapeutics (SPRO) Appoints Esther Rajavelu as CEO
-
-
-
-
-
-
-
Spero Therapeutics (SPRO) Reports SPR720 Phase 2a Interim Results, Provides a Business Update
-
-
-
-
-
437,947 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

